Profile data is unavailable for this security.
About the company
CONMED Corporation is a medical technology company that is engaged in the development, manufacturing, and sale on a global basis of surgical devices and related equipment. The Company's products consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures including dissociated two horizontal deviation and three horizontal deviation vision technologies. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, a line of cardiac monitoring products as well as electrosurgical generators and related instruments. Its products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology.
- Revenue in USD (TTM)978.50m
- Net income in USD54.14m
- Incorporated--
- Employees3.40k
- LocationConmed Corp11311 Concept BoulevardLARGO 33773United StatesUSA
- Phone+1 (727) 214-2974
- Fax+1 (302) 655-5049
- Websitehttps://www.conmed.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Axonics Inc | 150.27m | -68.17m | 2.91bn | 416.00 | -- | 5.77 | -- | 19.39 | -1.68 | -1.68 | 3.75 | 10.94 | 0.3287 | 1.14 | 7.56 | 361,221.20 | -14.91 | -- | -15.87 | -- | 61.94 | -- | -45.36 | -- | 10.73 | -7.31 | 0.0002 | -- | 707.06 | -- | 31.30 | -- | -- | -- |
| NuVasive, Inc. | 1.15bn | 1.85m | 2.92bn | 2.70k | 1,634.58 | 3.47 | 19.93 | 2.53 | 0.0346 | 0.0346 | 22.31 | 16.28 | 0.4808 | 1.01 | 5.78 | 427,098.50 | 0.0773 | 1.55 | 0.0973 | 1.81 | 72.31 | 72.62 | 0.1607 | 2.57 | 2.30 | 1.82 | 0.5121 | 0.00 | -10.06 | 5.31 | -156.95 | -- | 0.3312 | -- |
| Integer Holdings Corp | 1.11bn | 96.72m | 2.95bn | 7.50k | 30.61 | 2.24 | 16.61 | 2.66 | 2.92 | 2.92 | 33.39 | 39.84 | 0.4536 | 5.01 | 5.30 | 147,652.10 | 3.96 | 2.29 | 4.24 | 2.47 | 27.49 | 29.44 | 8.73 | 5.19 | 1.75 | 3.73 | 0.3372 | 0.00 | -14.68 | 6.05 | -15.30 | -- | 2.89 | -- |
| Patterson Companies, Inc. | 6.28bn | 165.57m | 3.13bn | 7.80k | 18.87 | 3.19 | 12.81 | 0.498 | 1.70 | 1.70 | 64.56 | 10.07 | 2.33 | 6.87 | 16.84 | 805,269.90 | 6.10 | -0.3475 | 9.84 | -0.492 | 19.54 | 21.73 | 2.62 | -0.1996 | 0.7877 | -- | 0.3914 | -- | 7.69 | 1.88 | 126.51 | -3.43 | -20.13 | 2.93 |
| Cytek Biosciences Inc | -100.00bn | -100.00bn | 3.22bn | 429.00 | -- | -- | -- | -- | -- | -- | -- | 1.37 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 6.76 | -- | 0.00 | -- | 60.39 | -- | 119.11 | -- | -- | -- |
| AtriCure Inc. | 243.13m | -56.68m | 3.27bn | 750.00 | -- | 8.50 | -- | 13.47 | -1.29 | -1.29 | 5.53 | 8.39 | 0.346 | 1.75 | 8.57 | 324,177.30 | -8.07 | -8.44 | -8.72 | -9.35 | 74.60 | 72.67 | -23.31 | -17.00 | 2.94 | -11.74 | 0.1251 | -- | -10.52 | 9.74 | -36.83 | -- | -17.12 | -- |
| Adapthealth Corp | 1.75bn | -90.37m | 3.31bn | 8.70k | -- | 1.74 | 99.53 | 1.89 | -1.97 | -1.97 | 18.82 | 14.53 | 0.6435 | 26.24 | 8.29 | 200,718.00 | -4.61 | -- | -5.47 | -- | 20.40 | -- | -7.16 | -- | 0.8407 | 1.19 | 0.5004 | -- | 102.15 | -- | -657.38 | -- | -- | -- |
| Haemonetics Corporation | 903.41m | 64.49m | 3.57bn | 2.71k | 55.59 | 5.27 | 23.30 | 3.95 | 1.26 | 1.26 | 17.69 | 13.27 | 0.5599 | 1.56 | 6.59 | 333,609.30 | 4.00 | 3.92 | 4.98 | 4.91 | 46.27 | 46.02 | 7.14 | 5.59 | 1.57 | 6.20 | 0.5367 | 0.00 | -11.94 | -0.859 | 3.85 | -- | -18.40 | -- |
| Merit Medical Systems, Inc. | 1.03bn | 28.24m | 3.92bn | 5.99k | 139.00 | 3.94 | 33.27 | 3.80 | 0.5006 | 0.5006 | 18.31 | 17.65 | 0.6141 | 2.80 | 7.06 | 172,185.20 | 1.68 | 1.36 | 1.90 | 1.52 | 43.56 | 43.60 | 2.74 | 2.17 | 1.21 | 12.00 | 0.2276 | 0.00 | -3.11 | 12.20 | -280.57 | -- | -1.41 | -- |
| Nevro Corp | 409.13m | -68.27m | 4.07bn | 843.00 | -- | 11.35 | -- | 9.94 | -1.97 | -1.97 | 11.83 | 10.28 | 0.6049 | 1.38 | 6.71 | 485,327.40 | -10.09 | -12.91 | -12.90 | -15.32 | 70.00 | 69.17 | -16.69 | -17.96 | 6.37 | -1.60 | 0.2901 | -- | -7.23 | 39.07 | 19.89 | -- | 3.77 | -- |
| Conmed Corp | 978.50m | 54.14m | 4.14bn | 3.40k | 82.07 | 5.56 | 32.82 | 4.23 | 1.73 | 1.73 | 31.79 | 25.53 | 0.5614 | 2.26 | 6.26 | 287,794.40 | 3.11 | 1.60 | 3.45 | 1.79 | 55.29 | 54.66 | 5.53 | 2.75 | 1.17 | 2.40 | 0.495 | 96.80 | -9.70 | 3.70 | -66.75 | -20.78 | -2.81 | 0.00 |
| Inari Medical Inc | 208.18m | 25.02m | 4.30bn | 456.00 | 192.12 | 19.35 | 157.64 | 20.66 | 0.4484 | 0.4484 | 3.73 | 4.45 | 0.8712 | 1.38 | 8.88 | 456,526.30 | 10.47 | -- | 11.49 | -- | 92.15 | -- | 12.02 | -- | 6.65 | 298.98 | 0.00 | -- | 173.17 | -- | 1,256.96 | -- | -- | -- |
| LivaNova PLC | 1.02bn | -379.12m | 4.46bn | 4.00k | -- | 3.95 | -- | 4.37 | -7.79 | -7.80 | 20.97 | 21.24 | 0.4171 | 2.33 | 5.55 | 255,431.00 | -15.47 | -4.59 | -19.29 | -5.53 | 65.30 | 64.85 | -37.09 | -11.05 | 0.9711 | -0.6777 | 0.3892 | -- | -13.83 | -- | -120.85 | -- | -- | -- |
| Pacific Biosciences of California Inc | 105.83m | -77.21m | 4.85bn | 412.00 | -- | 18.79 | -- | 45.86 | -0.4648 | -0.4648 | 0.5389 | 1.30 | 0.145 | 3.49 | 6.77 | 256,856.80 | -10.58 | -37.11 | -12.03 | -46.53 | 42.71 | 39.54 | -72.96 | -74.86 | 25.78 | -22.21 | 0.7762 | -- | -13.20 | -3.19 | 134.95 | -- | -19.16 | -- |
| Premier Inc | 1.72bn | 260.84m | 4.86bn | 2.60k | 16.62 | 2.18 | 11.42 | 2.82 | 2.38 | 2.38 | 14.64 | 18.20 | 0.5319 | 7.15 | 4.53 | 661,981.60 | 9.41 | 15.80 | 11.58 | 19.54 | 48.65 | 64.20 | 17.70 | 31.72 | 0.8453 | 15.07 | 0.1767 | 5.99 | 32.44 | 8.16 | -56.39 | -20.44 | 2.91 | -- |
| ICU Medical Inc | 1.28bn | 103.26m | 4.90bn | 7.90k | 48.42 | 3.14 | 25.66 | 3.83 | 4.77 | 4.77 | 59.04 | 73.43 | 0.6984 | 2.60 | 8.03 | 161,866.00 | 5.64 | 5.28 | 6.62 | 6.07 | 36.76 | 37.99 | 8.07 | 6.28 | 3.67 | 1,172.47 | 0.0019 | 0.00 | 0.3788 | 30.05 | -14.02 | 14.07 | 48.43 | -- |
Data as of Oct 15 2021. Currency figures normalised to Conmed Corp's reporting currency: US Dollar USD
53.13%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Jun 2021 | 4.29m | 14.70% |
| The Vanguard Group, Inc.as of 30 Jun 2021 | 3.07m | 10.51% |
| EARNEST Partners LLCas of 30 Jun 2021 | 1.63m | 5.59% |
| Champlain Investment Partners LLCas of 30 Jun 2021 | 1.48m | 5.06% |
| SSgA Funds Management, Inc.as of 30 Jun 2021 | 1.01m | 3.48% |
| Capital Research & Management Co. (Global Investors)as of 30 Jun 2021 | 946.00k | 3.24% |
| Principal Global Investors LLCas of 30 Jun 2021 | 853.15k | 2.93% |
| Macquarie Investment Management Business Trustas of 30 Jun 2021 | 770.28k | 2.64% |
| Dimensional Fund Advisors LPas of 30 Jun 2021 | 762.04k | 2.61% |
| Invesco Advisers, Inc.as of 30 Jun 2021 | 692.15k | 2.37% |
More ▼
Data from 30 Jun 2021 - 30 Jun 2021Source: FactSet Research Systems Inc.
